Skip to main content

From The Newsrooms

With opioid overdose deaths and stimulant use on the rise, FDA director Janet Woodcock highlighted for Rx Summit attendees several of the administration’s top initiatives to meet the challenge.
U.S. Rep. David Trone discussed the merger of his Freshmen Working Group on Addiction with the Bipartisan Opioid Task Force on Thursday at the Rx Summit. Rep. Lori Trahan, meanwhile, said she is reintroducing legislation to standardize SUD training for prescribers.
U.S. Secretary of State Antony Blinken shared the ways in which the U.S. State Department is working with other nations and various groups to disrupt the sophisticated operations of transnational criminal drug trade organizations.
Today’s addiction crisis is not the same as those that preceded it, and while there are reasons for concern, CDC director Rochelle Walensky, MD, MPH, told Rx Drug Abuse & Heroin Summit attendees in a session presented Wednesday morning that she also sees reasons for hope.
Researchers discuss their recent research that found having schizophrenia and dropping out of high school are among the factors that increase the likelihood of high utilization of inpatient psychiatric hospital services.
In this video, Randall Espinoza, MD, MPH, from the Geffen School of Medicine at UCLA, discusses the epidemiology, impact, and management of treatment-resistant depression in older adults.
To overcome setbacks in combating the nation’s opioid crisis caused by the COVID-19 pandemic, policies and resources will need to be crafted in ways that address systemic inequities that have exacerbated challenges for specific populations, Acting Assistant Secretary for Mental Health and Substance Use Tom Coderre told Rx Drug Abuse & Heroin Summit attendees on Wednesday evening.
ONDCP acting director Regina LaBelle outlined the seven priorities that will guide the administration's first year, and Admiral Charles Ray, vice commandant of the U.S. Coast Guard, explained how working with partner law enforcement agencies has helped in cracking down on maritime drug trafficking.
U.S. Rep. Hal Rogers told Rx Summit attendees on Tuesday that PDMPs are a great defense against the nation’s opioid threat, but concerns remain in a number of areas, including the future of Purdue Pharma. Sen. Mitch McConnell and Rep. Tom Cole, meanwhile, said the pandemic has heightened the need to double down in the opioid addiction fight.
NIH director Francis S. Collins, MD, PhD, and NIDA director Nora Volkow, MD, provided Rx Summit attendees with an update on several Helping to End Addiction Long-term (HEAL) projects that include treatment interventions and research around drug use trends.
Back to Top